Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amy L. Mahony
Observed names:
A. L. Mahony,
Amy Mahony,
Mahony, Amy
Institution:
New York State Psychiatric Institute
Observed institutions:
University of Minnesota,
University of Minnesota, Duluth,
New York State Psychiatric Institute,
Columbia University
ORCID:
0000-0002-9106-2818
Observed ORCID:
0000-0002-9106-2818
OpenAlex ID:
A5064430824
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial
2015
·
Frances R. Levin
, John J. Mariani
, et al.
·
JAMA Psychiatry
·
200
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial
2015
·
Frances R. Levin
, John J. Mariani
, et al.
·
Drug and Alcohol Dependence
·
113
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders
2016
·
Daniel P. Notzon
, Martina Pavlicova
, et al.
·
Journal of Attention Disorders
·
66
The Utility of Attention-Deficit/Hyperactivity Disorder Screening Instruments in Individuals Seeking Treatment for Substance Use Disorders
2012
·
Elias Dakwar
, Amy Mahony
, et al.
·
The Journal of Clinical Psychiatry
·
66
Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users
2019
·
Frances R. Levin
, John J. Mariani
, et al.
·
Drug and Alcohol Dependence
·
56
Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment‐seekers with cannabis use disorder
2018
·
Christina A. Brezing
, C. Jean Choi
, et al.
·
American Journal on Addictions
·
52
Quetiapine treatment for cannabis use disorder
2020
·
John J. Mariani
, Martina Pavlicova
, et al.
·
Drug and Alcohol Dependence
·
39
How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis
2018
·
Frances R. Levin
, C. Jean Choi
, et al.
·
Drug and Alcohol Dependence
·
38
Case Series: Rapid Induction Onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users
2020
·
John J. Mariani
, Amy Mahony
, et al.
·
American Journal on Addictions
·
30
Open‐label trial of a single‐day induction onto buprenorphine extended‐release injection for users of heroin and fentanyl
2021
·
John J. Mariani
, Amy L. Mahony
, et al.
·
American Journal on Addictions
·
26
Mixed‐amphetamine salts increase abstinence from marijuana in patients with co‐occurring attention‐deficit/hyperactivity disorder and cocaine dependence
2016
·
Daniel P. Notzon
, John J. Mariani
, et al.
·
American Journal on Addictions
·
25
Open-label pilot study of injectable naltrexone for cannabis dependence
2018
·
Daniel P. Notzon
, Meredith A. Kelly
, et al.
·
The American Journal of Drug and Alcohol Abuse
·
18
Open‐label pilot study of lisdexamfetamine for cocaine use disorder
2021
·
John J. Mariani
, C. Jean Choi
, et al.
·
The American Journal of Drug and Alcohol Abuse
·
16
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial
2021
·
Frances R. Levin
, John J. Mariani
, et al.
·
Drug and Alcohol Dependence
·
12
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder
2021
·
John J. Mariani
, Martina Pavlicova
, et al.
·
The American Journal of Drug and Alcohol Abuse
·
10
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial
2024
·
Frances R. Levin
, John J. Mariani
, et al.
·
Journal of Attention Disorders
·
8
Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial
2019
·
Elias Dakwar
, Amy Mahony
, et al.
·
The American Journal of Drug and Alcohol Abuse
·
5
Open-label pilot of lorcaserin (a serotonin 2C-receptor agonist) for cannabis use disorder
2023
·
Christina A. Brezing
, Mohammad Sibai
, et al.
·
Journal of Substance Use
·
3
PDF
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
2023
·
John J. Mariani
, Cale Basaraba
, et al.
·
The American Journal of Drug and Alcohol Abuse
·
2
Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence
2015
·
Daniel Notzon
, John J. Mariani
, et al.
·
Drug and Alcohol Dependence
·
2
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial
2024
·
Frances Levin
, John Mariani
, et al.
·
Drug and Alcohol Dependence
Craving and anxiety responses to laboratory stress for individuals seeking treatment for cannabis use disorder: A pilot study
2017
·
Matthew Olonoff
, Martina Pavlicova
, et al.
·
Drug and Alcohol Dependence
Cigarette smoking trajectories among comorbid cocaine-dependent and attention deficit/hyperactivity-disorder individuals treated with extended-release mixed amphetamine salts
2015
·
Brian Sou
, Andrew Glass
, et al.
·
Drug and Alcohol Dependence
Mixed amphetamine salts-extended release for ADHD adults with cocaine use disorder
2014
·
Frances R. Levin
, John J. Mariani
, et al.
·
Drug and Alcohol Dependence
Utility of various screening instruments for attention-deficit hyperactivity disorder (ADHD) in research participants seeking treatment for cocaine dependence
2009
·
Semhar Salina Berhane
, A. L. Mahony
, et al.
·
The Canadian Journal of Addiction
Show more works
View as search
Works count:
26
Citation count:
787
H-index:
13
I10-index:
15
Year
Topic
Type